Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,58118,600 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary Histiocytic neoplasms are clonal disorders of the monocyte/macrophage lineage that include Langerhans Cell Histiocytosis (LCH), Erdheim-Chester Disease (ECD), Juven...

$5.54M
USD
Completed NON-SBIR/STTR RPGS
Regulation of DGAT - dependent lipogenesis in colonic epithelial growth
NATIONAL CANCER INSTITUTE Tulane University of Louisiana United States 2021 – 2026

Abstract Obesity is characterized by systemic lipid accumulation, inflammation, and enhanced tumorigenesis in different tissues, including colon. With obesity, intracellular lipid...

$3.22M
USD
Completed NON-SBIR/STTR RPGS
Diversity Supplement Grant: TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2026

African American (AA) women presents with aggressive metastatic subtype of triple negative breast cancer (TNBC) compared to other ethnicities and experience greater mortality rates...

$489.9K
USD
Completed NON-SBIR/STTR RPGS
Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

Project Summary/Abstract Aneuploidy is defined as the existence of an abnormal number of chromosomes in a cell, and it has long been a defining characteristic of cancers. 90% of al...

$665.8K
USD
Completed SBIR-STTR RPGS
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
NATIONAL CANCER INSTITUTE Rise Therapeutics, Llc United States 2021 – 2025

Project Summary The goal of this project is to develop a novel oral drug, R-5780, which engages microbiome-associated Pattern Recognition Receptors (PRRs) to enhance the activity o...

$10.5M
USD
Completed NON-SBIR/STTR RPGS
Contribution of Nuclear S1P Signaling to Microtubule Targeting Agent-Induced Changes in Transcriptional Activity in Human iPS-SNs
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Chemotherapy induced peripheral neuropathy is a common dose-limiting toxicity that can reduce therapeutic effectiveness and impact quality of life for canc...

$619.8K
USD
Completed OTHER RESEARCH-RELATED
Elucidating the impact of DNA hypomethylation on genome organization and anti-tumor transcriptional programs
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY This proposed research career development program seeks to investigate the impact of DNA hypomethylation on genome organization and the mechanisms by which it drive...

$1.95M
USD
Completed NON-SBIR/STTR RPGS
Novel TYRO3 inhibitors for treatment of cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

TYRO3 is a member of the TAM (TYRO3, AXL, MERTK) family of receptor tyrosine kinases. All three family members are aberrantly expressed in cancer cells, where they function to prom...

$3.17M
USD
Completed NON-SBIR/STTR RPGS
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2026

ABSTRACT A patient's own T cells can be modified using gene therapy technology to express receptors, termed chimeric antigen receptors or CARs, which allow these immune T cell...

$6.31M
USD
Completed TRAINING, INDIVIDUAL
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2021 – 2024

Project Summary Resistance to alkylating agents, including monofunctional temozolomide (TMZ) and bifunctional CCNU, remains a major obstacle to improving outcomes for patients with...

$742.9K
USD
Completed NON-SBIR/STTR RPGS
Stem Cell-based Platform for Targeted Enzyme/Prodrug Therapy of Recurrent Ovarian Cancer
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

Project Summary: Ovarian cancer (OC) is associated with the highest mortality rate of all gynecologic malignancies in the United States. The low rate of survival is mainly due to t...

$3.82M
USD
Completed TRAINING, INDIVIDUAL
INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2024

PROJECT SUMMARY Mutations that inactivate DNA repair factors increase genome instability and cancer susceptibility. Predicting the phenotypic effects of mutations is confounded by...

$760.5K
USD
Completed TRAINING, INDIVIDUAL
Methods for improved detection of activated molecular pathways in cancer
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Studying tumors by quantifying gene expression via RNA-sequencing (RNA-seq) has proven crucial to elucidating their active biological pathways and processe...

$425K
USD
Completed TRAINING, INDIVIDUAL
Contribution of ERa/PR Crosstalk to Endocrine Therapy Resistance in the Context of ERa-Y537S
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Half of estrogen receptor (ERα)-positive breast cancer patients treated with endocrine therapies manifest intrinsic or acquired therapy resistance. One-thi...

$250.6K
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Regulation and Requirement of the NAD salvage pathway in CD8+ T Cell Exhaustion
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

Project Summary The development of checkpoint based cancer immunotherapy has revolutionized cancer treatment in the last decade. Although many otherwise untreatable patients have s...

$434.7K
USD
Completed NON-SBIR/STTR RPGS
Human papillomavirus in HIV associated lung cancers
NATIONAL CANCER INSTITUTE Tulane University of Louisiana United States 2021 – 2026

SUMMARY In recent years, the incidence of AIDS-defining cancers has dramatically decreased due to the HAART therapy. In contrast, the incidence of the non-AIDS-defining cancers (NA...

$3.47M
USD
Completed NON-SBIR/STTR RPGS
Effectiveness and implementation of a health system intervention to improve quality of cancer care for rural, underserved patients
NATIONAL CANCER INSTITUTE University of Iowa United States 2021 – 2026

PROJECT SUMMARY There is growing evidence that limited access to high-quality cancer treatment is one of the main drivers of higher cancer mortality rates among rural cancer patien...

$6M
USD
Completed NON-SBIR/STTR RPGS
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2026

Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma G protein-coupled receptors (GPCRs) represent the larges...

$5.26M
USD
Completed OTHER RESEARCH-RELATED
Lymph node regulation of metastatic fitness and reemergence
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2023

PROJECT SUMMARY Metastasis is the most dangerous stage of cancer, responsible for the vast majority of breast cancer-related deaths. Currently, we have no treatments that target me...

$10
USD
Completed NON-SBIR/STTR RPGS
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Project Summary/Abstract The molecular heterogeneity of cancers poses a major hurdle for treatment and drug discovery efforts. Previous studies have addressed this challenge by cha...

$4.13M
USD